Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 939 participants.

Also called NCT02471404

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 939 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02471404
Other papers using this trial's data
  • Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes Diabetes, obesity & metabolism, 2018-11 DOI, PubMed 29947099, PMC6220756 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Czechia, Germany, Hungary, Poland, Slovakia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02471404. Randomized; triple masking; primary purpose treatment. Start 2015-09-21 (actual); primary completion 2017-03-13 (actual). Results posted on 2019-03-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
Condition
Type 2 Diabetes Mellitus
Condition
Inadequate Glycaemic Control
Intervention (Drug)
Dapagliflozin
Intervention (Drug)
Saxagliptin
Intervention (Drug)
Glimepiride
Intervention (Drug)
Placebo for dapagliflozin
Intervention (Drug)
Placebo for saxagliptin
Intervention (Drug)
Placebo for glimepiride
Lead sponsor
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct02471404
Content hash
f08efcc5f28f170dd8f510cf562231bc5923e9750e769c473cfef8fd4e1e91ad